In this episode, Dr. Douglas Graham, Chief of the Aflac Cancer and Blood Disorders Center, shares progress in pediatric leukemia and sickle cell disease treatments, the impact of a 30-year partnership with Aflac, and breakthroughs in precision medicine, CAR T-cell therapy, and gene therapy that are reshaping outcomes for children and families.
Dr. Douglas Graham, Chief of the Aflac Cancer and Blood Disorders Center
Advertisement
Advertisement
Next Up in Becker’s Pediatric Leadership Podcast
-
In this episode, Thomas Carey, PharmD, Senior Director, Pharmacy Services, UW Northern Illinois, shares how the organization elevated its Med…
-
In this episode,Caswell Samms III, Executive Vice President and CFO of Nemours Children’s Health, discusses financial priorities for 2026, including…
-
In this episode, Jakob Emerson, Associate News Director at Becker’s Healthcare, breaks down the latest trends in the payer landscape,…
Join the 500,000+ healthcare executives who start their day with Becker’s
Advertisement
Comments are closed.